Spasticity
📧 Sign up to get email alerts when something new happens for Spasticity.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-07-09FDA Approved: BACLOFEN — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved an original application for a generic baclofen product from Unichem Pharmaceuticals (USA), Inc.
-
FDA approval · 2020-03-24FDA Approved: TIZANIDINE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved a generic version of tizanidine hydrochloride from Aurobindo Pharma Limited via Original Application (ANDA 213544) for the trea…
-
FDA approval · 2019-12-26FDA Approved: DIAZEPAM — Original Application (Natco Pharma USA LLC)
FDA approved Natco Pharma USA LLC's original application for a generic diazepam product, enabling its marketing in the United States.
-
CLINICAL_TRIALS trial_result · 2019-11-06Clinical Trial Update: A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis [Phase 2]
A Phase 2 clinical trial evaluating IPX056 for spasticity in subjects with multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-18Clinical Trial Update: A Phase III Study to Evaluate the Efficacy and Safety of GSK1358820 in Subjects With Post-stroke Upper Limb Spasticity [Phase 3]
Phase III trial evaluating GSK1358820 for post-stroke upper limb spasticity has completed with results posted in 2019.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-07-30FDA Approved: BACLOFEN — Original Application (Sagent Pharmaceuticals)
FDA approved baclofen from Sagent Pharmaceuticals under an original ANDA, confirming the availability of generic baclofen for treating muscl…
-
CLINICAL_TRIALS trial_result · 2019-06-18Clinical Trial Update: Efficacy and Safety of SPARC0921 in Subjects With Spasticity [Phase 3]
Phase 3 trial results for SPARC0921 in spasticity have been completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-05-03Clinical Trial Update: Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump [Phase 3]
Phase 3 safety study of intrathecal baclofen injection (3 mg/mL) using a programmable pump completed.
-
CLINICAL_TRIALS trial_result · 2019-03-29Clinical Trial Update: MEDITOXIN® Versus BOTOX® in the Treatment of Post-stroke Spasticity of the Upper Limb Spasticity [Phase 3]
Phase 3 trial comparing MEDITOXIN to BOTOX for upper limb spasticity after stroke has completed with results posted.
-
FDA approval · 2019-03-27FDA Approved: TIZANIDNE HYDROCHLORIDE — Original Application (Ascend Laboratories, LLC)
FDA approved Tizanidine Hydrochloride as an original generic drug application for the management of spasticity in adults with multiple scler…
-
FDA approval · 2019-03-26FDA Approved: TIZANIDINE HYDROCHLORIDE — Original Application (Nivagen Pharmaceuticals, Inc.)
FDA approved the original ANDA for tizanidine hydrochloride from Nivagen Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2019-03-12Clinical Trial Update: Safety Study of SPARC1104 [Phase 3]
Phase 3 safety study of SPARC1104 for spasticity has completed with results posted.
-
FDA approval · 2019-03-12FDA Approved: TIZANIDINE HYDROCHLORIDE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approved Ingenus Pharmaceuticals' original application for a generic tizanidine hydrochloride product.
-
CLINICAL_TRIALS trial_result · 2019-02-18Clinical Trial Update: Comparing Lower-concentration Dysport Treatment Targeted to the Neuromuscular Junction With Current Clinical Practice [Phase 3]
A Phase 3 trial comparing lower-concentration Dysport targeted to the neuromuscular junction versus current clinical practice in arm spastic…
-
FDA approval · 2019-01-25FDA Approved: TIZANIDINE — Original Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories, LLC's original ANDA for tizanidine, establishing a generic version of the muscle relaxant.
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: Long-term Surveillance of the MedStream Programmable Infusion System
This update reports the termination of a long-term surveillance study of the MedStream programmable infusion system for spasticity.
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: Study of SPARC1103 in Subjects With Spasticity [Phase 2]
Phase 2 clinical trial of SPARC1103 in subjects with spasticity has completed with results posted.
-
FDA approval · 2018-11-23FDA Approved: BACLOFEN — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved the Original Application for Baclofen from Zydus Pharmaceuticals (USA) Inc., establishing a generic baclofen product. Baclofen …
-
CLINICAL_TRIALS trial_result · 2018-05-07Clinical Trial Update: Dose-response Relationship of Botullinum Toxin (DWP 450) for Finger Flexor Spasticity [Phase 4]
Phase 4 clinical trial update examining the dose-response relationship of Botulinum toxin DWP-450 for finger flexor spasticity, sponsored by…
-
CLINICAL_TRIALS trial_result · 2018-05-01Clinical Trial Update: Optical Stimulation in Peripheral Nerves for Select Rhizotomy Procedures
The study evaluating optical stimulation of peripheral nerves to assist select rhizotomy procedures for spasticity has completed.
-
CLINICAL_TRIALS trial_result · 2018-02-15Clinical Trial Update: SISTERS: Spasticity In Stroke Study - Randomized Study [Phase 4]
A Phase 4 randomized trial update for the SISTERS study evaluating interventions for severe spasticity after stroke; results completed with …
-
CLINICAL_TRIALS trial_result · 2017-06-07Clinical Trial Update: JCP Study of Investigation of Patient Background Characteristics
GlaxoSmithKline sponsored a completed clinical trial (NCT01332474) examining patient background characteristics in spasticity and post-strok…
-
CLINICAL_TRIALS research · 2017-05-30Clinical Trial Update: Modulation of H-reflex After Application of Electric Currents in Healthy People [NA]
Clinical trial update from University of Castilla-La Mancha on modulation of the H-reflex by electrical currents in healthy individuals, wit…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Developing and Testing a Comprehensive MS Spasticity Management Program [Phase 2]
Phase 2 update reporting completion and posting of results for a comprehensive spasticity management program in multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: Shockwaves Therapy and Botulinum Toxin for the Treatment of Spasticity in Patients With Cerebral Palsy. A Cross Over RCT [Phase 1]
A Phase 1 cross-over randomized trial evaluating shockwave therapy in combination with botulinum toxin to treat spasticity in cerebral palsy…